Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study [NA]
A prospective validation trial is evaluating an AI-based 3D kidney model to assist partial nephrectomy in renal cell carcinoma and is curren…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer [Phase 2]
A Phase 2 trial update evaluating imaging approaches for post-operative staging in kidney cancer, comparing 89Zr-DFO-GmAb PET/CT to contrast…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
An ongoing clinical trial is investigating the role of TTV during first-line immunotherapy in patients with renal cell carcinoma and is curr…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery [Phase 3]
Phase 3 trial comparing hippocampus-sparing whole-brain radiotherapy to stereotactic radiosurgery for patients with brain metastases from va…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR) [Phase 2]
Phase 2 study evaluating nivolumab as pre- and post-operative therapy for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of nivolumab in combination with ipilimumab for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
This update announces that the PRO-RCC study is actively recruiting to establish a prospective infrastructure for renal cell carcinoma resea…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO [Phase 3]
A Phase 3 trial is evaluating whether an immune-oncology therapy given every three months after six months of standard administration is as …
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors [Phase 3]
A Phase 3 trial evaluating whether pausing versus continuing treatment is preferred in metastatic renal cell carcinoma patients who have goo…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy [NA]
This clinical trial update describes a study evaluating goal-directed hemodynamic management to reduce kidney injury following radical nephr…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of CD70-targeted CAR-T therapy for CD70-positive advanced/metastatic solid tumors is currently recruiting, with potential indi…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of AWT020 in patients with advanced malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Preop Laxatives in Robotic Urologic Surgery [Phase 4]
Phase 4 clinical trial evaluating preoperative laxatives to optimize robotic urologic surgery in patients with prostate cancer and renal cel…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
A clinical trial investigating CAIX-targeted PET imaging in renal cancer patients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management [NA]
A clinical trial evaluating partial-volume high-dose irradiation to improve intra-tumor control in renal cell carcinoma, alongside standard …
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of talazoparib and axitinib for previously treated advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
This ClinicalTrials.gov update describes a study evaluating the systemic anti-tumor activity and safety of combining SBRT with concurrent PD…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer [Phase 1]
Phase 1 study evaluating the safety of combining radiation therapy with pembrolizumab (MK-3475) in patients with recurrent/metastatic head a…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)
A prospective study to evaluate the implementation of a shared decision-making strategy for renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology [NA]
PRO-VISION is a clinical trial evaluating patient-reported outcomes for side effects of VEGF inhibitors in renal cell carcinoma; the study i…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors [NA]
This completed clinical trial evaluated pentafecta outcomes in open and laparoscopic partial nephrectomy for localized renal tumors.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes
The update outlines imaging-guided classification for endophytic renal tumors and evaluates partial nephrectomy strategies and outcomes.